4.4 Review

Human endothelial dysfunction: EDRFs

Journal

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
Volume 459, Issue 6, Pages 1005-1013

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00424-010-0822-4

Keywords

Endothelium; Endothelium-derived relaxing factor (EDRF); Nitric oxide; Prostacyclin; Endothelium-derived hyperpolarizing factor

Categories

Funding

  1. Swiss National Science Foundation [3100-068118, 310030-118353]
  2. Mercator
  3. Bonizi-Theler
  4. Swiss Heart Foundation

Ask authors/readers for more resources

Since the detection of nitric oxide two and a half decades ago, there has been an incredible boost in endothelial function research, which is fascinating the research community. Physiologically, endothelial cells synthesize a number of vasoactive substances. In particular, several endothelium-derived relaxing factors (EDRFs) have been characterized, whereby nitric oxide is the most important. In humans, endothelial dysfunction is one of the first clinically detectable alterations in the development of atherosclerosis and is characterized by an imbalance in the release of vasoactive substances. Thus, it is the aim of this article to give an overview about endothelial function in humans, to summarize the different possibilities to assess endothelial function in this species, and to give an overview of the role of EDRFs in different cardiovascular diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available